KRLS-004 is under clinical development by Kirilys Therapeutics and currently in Phase I for Renal Cell Carcinoma.

Oberotatug ravtansine is under clinical development by Oxford BioTherapeutics and currently in Phase I for Ovarian Cancer.

Objective The relationship between low income and adverse perinatal outcomes, such as low birth weight and developmental ...

Objective To explore associations between maternal body mass index (BMI) in early pregnancy and childhood infections. Design Birth cohort study linked to primary care records. Setting Bradford, UK.